BGI Genomics Can Develop DNA Tech During Patent Appeal
Chinese genetics company BGI Genomics can continue developing its DNA sequencing products as it appeals the scope of a preliminary injunction that gave Illumina total control of the U.S. market for...To view the full article, register now.
Already a subscriber? Click here to view full article